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Abstract: 5-Formyl-2’-deoxycytosine (fdC) is a recently discovered epigenetic base in the genome of stem cells, with yet unknown 
functions. Sequencing data show that the base is enriched in CpG islands of promoters and hence likely involved in the regulation of 
transcription during cellular differentiation. fdC is known to be recognized and excised by the enzyme thymine-DNA-glycosylase (Tdg). 
As such, fdC is believed to function as an intermediate during active demethylation. In order to understand the function of the new 
epigenetic base fdC, it is important to analyze its formation and removal at defined genomic sites. Here, we report a new method that 
combines sequence-specific chemical derivatization of fdC with droplet digital PCR that enables such analysis. We show initial data, 
indicating that the repair protein Tdg removes only 50% of the fdCs at a given genomic site, arguing that fdC is a semi-permanent base.  
DNA contains besides the sequence information a second, epigenetic information level, which encodes how actively the controlled 
gene is transcribed.[1] Today, next to the four canonical bases, four additional epigenetic bases are known.[2] These are 5-methylcytosine 
(5mC), 5-hydroxymethylcytosine (5hmC),[3] 5-formylcytosine (5fC),[4] and 5-carboxycytosine (5caC).[5] (Figure 1a) Over the last years, 
sensitive mass spectrometry-based methods have helped to reveal the global levels of these epigenetic bases in stem cells[4,6] and 
tissues including the brain.[7] In order to learn about the levels and the distribution of the epigenetic bases at specific sites in the genome, 
different sequencing methods were developed[8] in which selective chemical derivatization of the bases is performed[9], sometimes in 
combination with bisulfite sequencing.[9c,10] Although these methods provide information about the distribution of the bases at a given 
time point, it is a hallmark of epigenetic information that it changes dynamically. To gain deeper insight into the dynamics of the 
epigenetic information layer at a single position in the genome, it is therefore essential to develop methods that allow following the 
changes of, for example, fdC at a specific location in the genome over time.[11] A perfect method will ultimately allow parallel monitoring 
of fdC dynamics at different genomic sites.  
The central question addressed in this manuscript is: Are the measured global data of the past averages from different processes at 
different positions in the genome, or do they reflect what is happening at an individual site in the genome. To answer this question, we 
developed a sequence specific chemical derivatization method that allows in combination with droplet digital PCR to monitor the 
epigenetic base fdC at different loci directly in the genome of stem cells.  
Figure 1. a) Structures of cytosine epigenetic modifications; b) Schematic representation of the fdC detection strategy, and used building blocks including the click 
chemistry-based assembly of the rU* probe molecule. 
 
 For the sequence specific localization of fdC in the genome, we utilize a small probe oligonucleotide (Figure 1b, Table S1), which 
contains a hydroxylamine tether that is able to form a covalent linkage with fdC so that the probe strand is subsequently tightly bound 
to the target.[4] We examined systematically different linker lengths, linker attachment points and distances. Best results were obtained 
when we incorporated the 2’-O-propargyl uridine using its phosphoramidite 1 into the probe oligonucleotide and attached the azido-C4-
hydroxylamine 2 using the Cu(I)-catalyzed version (click reaction) of the Huisgen-reaction.[12] We protected the hydroxylamine unit for 
the click reaction with a monomethoxytrityl group (MMTr), which was cleaved afterwards with acetic acid at 25°C. This brief exposure 
of the probe oligonucleotide to acidic conditions did not cause significant depurination. After solid-phase synthesis, click modification 
of the oligonucleotide and a final purification step (Figure S1), we obtained oligonucleotides with different sequences and lengths 
containing an rU-hydroxylamine base (rU*) at different positions for reaction with the fdC-base on the target strand. For the following 
experiments, we prepared 13-mer long oligonucleotides. 
 
To investigate at which position the linker in the probe strand would react best with fdC in the target strand, we varied the position 
of rU* relative to fdC and explored different reaction conditions (data not shown). Excellent results were finally obtained when probe 
strand P1, containing rU* exactly 4 basepairs in 5’ direction relative to fdC, was hybridized to the fdC target strand T1 in the presence 
of catalytic amounts of 4-methoxyaniline (Fig 2a). With this catalyst, the crosslinking reaction is complete after 24 h with yields 
exceeding 95%. Without the catalyst, only about 50% yield could be obtained (Fig 2b).  
In order to increase the rate of the reaction, we tested other catalysts. We observed the best results when we used 1,4-
diaminobenzene as a catalyst, in which case the crosslinking reaction between T1 and P1 is completed already after 3 h (Figure 2c). 
Duplex formation (T1:P1) was analyzed using denaturing PAGE and quantified by fluorescence (Figure 2d).  
When fdC is located one base pair further away from rU* without changing the probe strand, we observe slower reaction (Figure 
S2). These results show that rU* placed four or five bases away from fdC in 5’-direction to fdC allows the tether to reach the formyl 
group of fdC via the major groove of the duplex (Figure S3).  
Figure 2. Denaturing PAGE gel showing the duplex formation between T1 and P1 at 25°C: a) with the catalyst 4-methoxyaniline; b) without a catalyst; c) with the 
catalyst 1,4-diaminobenzene; d) Quantification of the DNA duplex formation during the reaction. Black: catalyst 4-methoxyaniline, blue: no catalyst, red: catalyst 
1,4-diaminobenzene. Error bars represent the standard error of the mean calculated from three replicates. Conditions: 2 μM oligonucleotides, 100 mM NaCl, 10 mM 
NaOAc buffer pH 6.0, 10 mM 4-methoxyaniline. M = single strand marker. The time point 0 is after re-annealing. 
 
MALDI-TOF data confirmed that the crosslinks form as expected (Figure S4). For the reacted duplex T1:P1, we obtained the 
correct molecular weight for the duplex with m/zfound = 8081.9 (m/zcalc = 8084.7). As expected, the oxime formation reaction between 
T1 and P1 leads to a higher melting temperature of the hybridized and reacted duplex (Figure S5). Typically, we observed that the un-
crosslinked 13-mer duplex melts at around 44°C. The duplex after crosslink formation shows a melting temperature of above 80°C. 
Because pyrimidine bases are able to react with nucleophiles also at the C6 position in a Michael-type reaction, which is the basis 
for bisulfite sequencing, we next tested if the reaction of rU* is possible with other pyrimidines (Figure 3). To our delight, hybridization 
of the rU*-containing probe strand with target strands containing dT, dC, mdC, hmdC and cadC (T3-8) gave no reaction. Reaction is, 
however, observed with abasic sites. This is important because fdC and cadC are substrates for base excision repair and hence could 
in principle be precursors for abasic sites.[13] In this sense, rU* always reports the presence of fdC and also potentially of fdC and cadC 
derived abasic sites.  
Figure 3. Denaturing PAGE gel showing duplex formation of T3-8 and P1 at 25°C after 24 h. 
We finally turned the sequence specific fdC detection possibility into a method for detecting single fdC bases at a defined position 
in whole genomes. To this end, we coupled the chemistry to droplet digital PCR[14]-based amplification and readout.  
Genomic target DNA (Tg) was in the first step isolated from mouse embryonic stem cells (mESCs) at different time points during 
priming from naïve cells. We also isolated genomic DNA from mESCs with a knockout of the Tdg repair enzyme (Tdg-/-) to block excision 
and repair of fdC and cadC. We finally also isolated genomic DNA from mESCs lacking any of the three methyltransferases (Dnmt1, 
3a and 3b). These stem cells lack mdC and are hence unable to produce the oxidized xdC (x = hm, f and ca) epigenetic bases. This 
genomic DNA served in our studies consequently as a negative control. For analysis, we selected two different fdC sites that were 
reported to have high fdC contents.[10c] We focused initially on the 30,020,539th site of chromosome 16 Mus musculus (MM9) located 
on the exon 3 of 632428C04Rik. It was found to contain 23% of fdC based on redBS-Sequencing. The second site we studied was the 
8,846,677th site of chromosome 15 which is located in non-coding DNA. This site was reported to contain 32% of fdC. 
For the first site, we reacted a 25-mer probe (P2, SI) containing the rU* base with Tg using 1,4-diaminobenzene as catalyst. In the 
absence of fdC, a covalent bond between P2 and Tg cannot form. To remove the excess of probe, we loaded the Tg:P2 complex onto 
an NEB Monarch DNA cleanup column and rinsed the column with wash buffer to elute oligonucleotides shorter than 50-mer, which is 
the unbound P2. After this washing, we eluted the Tg:P2 with TE buffer. UV/Vis analysis of the eluted material showed a typical gDNA 
spectrum. We next added a 70-mer 5’-phosphorylated reporter strand (R1, SI) which hybridizes with an 18-nt stretch directly adjacent 
to the probe strand and ligated both probe and the reporter at 60°C by addition of Ampligase to form R1-P2 as depicted schematically 
in Figure 4a.  
Figure 4. The fdC sequencing method: a) Schematic representation of the method, black line: gDNA; red segments: fdC probe; blue segments: reporter strands; 
arrows: PCR primer pairs; b) Typical 2-D plot of droplet fluorescence; c) Cluster ratios for position 1 in Tdg-/-, Tdg+/- and Dnmt TKO mES cells; d) Global fdC 
quantification in Tdg-/-, Tdg+/- and Dnmt TKO mES cells using our LC-MS method; e) Cluster ratios for position 2 in Tdg-/- and Tdg+/- mES cells; f) Cluster ratios 
for position 1 in wild-type mES cells at different days after priming; g) Global quantification data for the wild-type mES cells measured by LC-MS. 
 
We next added two sets of primers to the assay (blue and green arrows, Figure 4a) to amplify the ligation product relative to the 
target duplex. Importantly, the blue primers recognize only the hybrid R1-P2 probe generated in the ligation step while the green primers 
indicate the presence of gDNA. The amplification was monitored with two different TaqMan probes which showed fluorescence at 520 
and 556 nm. This relative detection is needed to normalize on the amount of input gDNA. Because conventional real-time PCR is 
known to become inaccurate when copy number differences less than the 10-fold need to be resolved, we used droplet digital PCR. In 
this method, small droplets are generated with one droplet containing a maximum of one of the fully assembled analysis constructs 
shown in Figure 4a. The PCR reaction takes place in the droplets, producing a specific signal. Subsequent color-counting of each 
individual droplet yields numbers from which one can accurately calculate the amount of fdC, even if the fdC values are very low. A 
representative plot of the data is given in Figure 4b. Empty drops give no PCR signal (black dots in Figure 4b). Drops containing only 
Tg give only the PCR signal from the green primers (green dots in Figure 4b). Blue dots are obtained due to the dissociation of the 
ligated product R1-P2 from Tg in the ligation process which is performed at 60°C for 10 h. The red signals are finally generated from 
droplets that contain both PCR products. For the calculation, please see the Supporting Information.  
 
Using the method, we first studied mES cells lacking the Tdg enzyme (Tdg-/-). A rather high level of 28.5% fdC was measured at 
the first locus (Figure 4c) in agreement with the results from redBS-seq.[10c] When we performed the study, however, with mESCs 
having an active Tdg repair enzyme (Tdg+/-) we measured that the fdC level drops at this particular position to 15.7% (Figure 4c). This 
is very important because it shows that Tdg removes only half of the fdCs at a given site and also unusual due to the fact that repair 
glycosylases are known to find basically all possible substrates. The result underpins the high dynamics of fdC formation and repair at 
a given site. When we studied the fdC content at this location in mESCs lacking any methyltransferase (Dnmt TKO) the fdC level drops 
as expected to a little more than 5%, showing that the reported levels of fdC in the Tdg+/- cells are real and not an artifact. In order to 
elucidate if single-site fdC levels (Figure 4c) follow global genomic fdC levels, we quantified the total levels of fdC in these cells (Figure 
4d). These global data are in good agreement with the data obtained from single site fdC quantifications. Thus, our new data make a 
scenario where fdC is fully removed at one site and shielded from repair at another place unlikely. Instead, fdC is even at a given 
position only partially removed in a cell population. Alternatively, it may be that Tdg removes fdC differently on the two chromosomes, 
which however needs further investigation. 
In order to verify the data, we repeated the Tdg study at a second genomic site (8,846,677th nucleoside of chromosome 15). For 
this site, we designed a new probe strand P3 and a new reporter strand R2 and performed again ddPCR with two sets of primers 
(Figure S5). Comparing the data obtained from Tdg-/- cells with the data from Tdg+/- cells, again only a 50% reduction of the fdC level 
is shown at this position, in full agreement with the data above obtained from the first position (Figure 4e).  
We finally performed a kinetic study in which we monitored the fdC development at the first position during priming of stem cells 
(Figure 4f). We see that the fdC levels rise at the given position with a strong increase in the early phase of priming, followed by a small 
decline phase and finally stable values (Figure 4f) again in agreement with the global data that we again measured using our reported 
method (Fig 4g).  
 
The fact that our method is providing the same trends as seen in the global data at a single genomic site makes us confident that 
our method is robust and reliable reporting what happens at an individual site. Because single-site and global data go in parallel, we 
have now first evidence that the reported global trends are reflecting what happens at each individual fdC site, rather than evening out 
largely different dynamics at separate sites. Another interesting result of this study is that the repair enzyme Tdg removes only half of 
the fdC bases at a given genomic site in an mESC population, which argues that fdC is a semi-permanent base at a given position in 
the genome. 
Experimental Section 
Probe crosslinking gDNA solution (1.2 μg), fdC probe (1 μM, 2 μL), NaH2PO4-Na2HPO4 buffer (200 mM, pH = 6.0, 2 μL), NaCl aq. (1.5 M, 2μL), and 
ddH2O were mixed to a final volume of 18 μL. The mixture was heated to 95°C for 3 min and then cooled down rapidly to 25°C. 1,4-Benzenediamine aq. 
(10 mM, 2 μL) was added and the reaction vial was shaken for 6 h at 25°C. The mixture was neutralized with Na2HPO4 aq. (200 mM, 40 μL) before 
purification with the NEB Monarch PCR DNA Cleanup Kit.  
Ligation The above described gDNA solution (300 ng), reporter strand (20 nM, 1 μL), Ampligase reaction buffer (10×, 2 μL), Ampligase from Epicentre 
(5 U/μL, 2 μL, 10 U) and ddH2O were mixed to a final volume of 20 μL. The mixture was heated to 95°C for 3 min, and then 94°C for 1 min, 60°C for 1 h 
and back to 94°C for 10 cycles. Then, the reaction mixture was diluted with Tris-HCl buffer (200 mM, pH = 7.6, 50 μL) before purification using the NEB 
Monarch PCR DNA Cleanup Kit. 
Droplet digital PCR ddPCR was conducted on a Bio-Rad QX100 ddPCR System. For one reaction, gDNA (6 ng), four primers (18 μM each, 1 μL), two 
TaqMan probes (5 μM each, 1 μL), digital PCR Supermix for Probes (no dUTP, 2×, 10 μL), and ddH2O were mixed to a final volume of 20 μL. PCR cycle: 
95°C for 10 min, 94°C for 30 sec and 64°C for 1 min for 35 cycles, then 98°C for 10 min and cooled down to 12°C, with a temperature ramp of 2°C/s. For 
a detailed description please see the Supporting Information. 
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1. General methods of organic synthesis 
 
Chemicals were purchased from Sigma-Aldrich and used without further purification. 
The solvents for organic synthesis were of reagent grade and purified by distillation. 
Solutions were concentrated in vacuo on a Heidolph rotary evaporator with a Vario 
PC2001 diaphragm pump by Vacuubrand. All mixed solvent systems are reported as 
v/v solutions. All reactions were monitored by thin-layer chromatography (TLC), 
performed on Merck 60 (silica gel F254) plates. Chromatographic purification of 
products was accomplished using flash column chromatography on silica gel 
(230-400 mesh) purchased from Merck.  
1H- and 13C-NMR spectra were recorded in deuterated solvents on Bruker ARX 400 
spectrometers and calibrated to the residual solvent peak. Chemical shifts (δ, ppm) are 
quoted relative to the residual solvent peak as internal standard and coupling constants 
(J) are corrected and quoted to the nearest 0.1 Hz. Multiplicities are abbreviated as 
follows: s = singlet, d = doublet, t = triplet, m = multiplet. 
 




1,4-Dibromobutane 1 (5.9 mL, 49.4 mmol, 2.0 eq.) was added to a solution of 
N-hydroxyphthalimide (PhthNOH, 4.0 g, 24.5 mmol, 1.0 eq.) and triethylamine (7.5 
mL, 53.6 mmol, 2.2 eq.) in anhydrous dimethylformamide. The mixture was stirred at 
room temperature for 24 h. The reaction was diluted with water, and the aqueous 
phase was extracted three times with ethyl acetate. The combined organic phases were 
dried over MgSO4, filtered and concentrated to give the crude product 2 (5.02 g, 16.9 
mmol, 0.69 eq.) as a white solid. The residue was dissolved in anhydrous 
dimethylformamide and sodium azide (1.32 g, 20.6 mmol, 0.85 eq.) was added. The 
mixture was stirred at room temperature for 2 h, diluted with water and extracted with 
ethyl acetate three times. The combined organic phases were dried over MgSO4, 
filtered and concentrated. The crude was purified by flash chromatography on silica 
gel (iso-hexane/ethyl acetate 10:1→ 2:1) to give 3 (3.97 g, 15.2 mmol, 0.62 eq.) as a 
yellow oil. The oil was redissolved in hydrazine monohydrate (1.1 mL, 22.8 mmol, 
0.93 eq.) and dichloromethane (10 mL). The mixture was stirred at room temperature 
for 24 h and then filtered. The solution was diluted with dichloromethane and washed 




filtered and concentrated to give 4 (1.81 g, 13.9 mmol, 57% yield over three steps) as 
a colorless oil. 
 
Rf = 0.42 (DCM/ MeOH 10:1). 
1H-NMR (400 MHz, CDCl3): δ = 3.70 (t, 
3JH,H = 5.6 Hz, 2H, O-CH2-CH2), 3.38 (t, 
3JH,H = 6.4 Hz, 2H, CH2-N3), 1.68−1.64 (m, 4H, CH2-CH2-CH2-CH2).   
13C-NMR (100 MHz, CDCl3): δ = 75.1 (-O-CH2-CH2), 51.2 (CH2-N3), 25.6 (CH2), 
25.5 (CH2). 









O-(4-Azidobutyl)hydroxylamine 4 (1.88 g, 14.4 mmol, 1.0 eq.) was dissolved in 
anhydrous dichloromethane (40 mL). 4-Monomethoxytritylchloride (MMTr-Cl, 4.91 
g, 15.9 mmol, 1.1 eq.) and diisopropylethylamine (5.0 mL, 28.9 mmol, 2.0 eq.) was 
added to the mixture at 0°C. The reaction was stirred at room temperature for 2 h, 
diluted with dichloromethane, washed with saturated NaHCO3, dried over MgSO4, 
filtered and concentrated. The crude was purified by flash chromatography on silica 
gel (iso-hexanes/ethyl acetate 15:1 + 3% triethylamine) to give 5 (4.89 4g, 12.2 mmol, 
84%) as a yellowish oil. 
 
Rf = 0.64 (iso-hexane/ ethyl acetate 10:1 + 3% triethylamine). 
1H-NMR (400 MHz, CDCl3): δ = 7.31−7.18 (m, 12H, 12 × CArH), 6.79 (d, 
3JH,H = 8.8 
Hz, 2H, 2 × CH3-O-C-CH), 3.76 (s, 3H, O-CH3), 3.65 (t, 
3JH,H = 6.0 Hz, 2H, 
O-CH2-CH2), 3.05 (t, 
3JH,H = 6.8 Hz, 2H, N3-CH2), 1.52−1.37 (m, 4H, 
N3-CH2-CH2-CH2-CH2).  
13C-NMR (100 MHz, CDCl3): δ = 158.3 (CH3-O-C), 144.6 (2 × CAr), 136.6 (CAr), 
130.2 (2 × CAr), 129.0 (4 × CAr), 127.6 (4 × CAr), 126.7 (2 × CAr), 112.9 (2 × CAr), 
77.2 (O-NH-C), 73.2 (O-CH2), 55.2 (O-CH3), 51.1 (N3-CH2), 25.8 (N3-CH2-CH2), 
25.5 (O-CH2-CH2). 
















4. General methods for oligonucleotide synthesis 
 
DNA Oligonucleotide synthesis was performed on an Applied Biosystems 
Incorporated 394 automated synthesizer. Phosphoramidites and solid supports 
columns were purchased from Glen Research, Link Technology, and ChemGene 
Corporation. Oligodeoxynucleotides were synthesized in a 1 μmol scale with 
standard DNA synthesis cycles (trityl off mode). Coupling time for modified 
nucleosides was extended to 10 min. The oligonucleotide was cleaved using conc. 
ammonium hydroxide aq. at 25 °C for 17 h. The aqueous solution was then collected 
and evaporated in a SpeedVac concentrator, and the pellet was redissolved in ddH2O.  
Analytical RP-HPLC was performed using a Macherey-Nagel Nucleodur 100-3 
C18ec column on 2695 Separation Module equipped with a Waters Alliance 2996 
Photodiode Array Detector using a flow of 0.5 mL/min. Semi-preparative RP-HPLC 
was performed using a Macherey-Nagel C18 column (5 mm, 9.4 × 250 mm) on 
Waters Breeze 2487 Dual λ Array Detector, 1525 Binary HPLC Pump. Conditions: 
Buffer A, 0.1 M TEAA (triethylammonium acetate) in water; buffer B, 0.1 M TEAA 
in 80% acetonitrile.  
The purified fractions were concentrated and characterized by Matrix Assisted Laser 
Desorption Ionization Time of Flight (MALDI-TOF) on a Bruker Daltonics Autoflex 
II instrument. The concentration of the oligonucleotide solutions was calculated from 
the UV absorbance at 260 nm on a Nanodrop ND-1000 spectrophotometer. Extinction 
coefficients of the oligonucleotides at 260 nm were calculated by addition of the 
extinction coefficients of the individual nucleobases: dA 15.0 L/(mmol⋅cm), dC 7.1 
L/(mmol⋅cm), dG 12.0 L/(mmol⋅cm), dT 8.4 L/(mmol⋅cm), mdC 7.8 L/(mmol⋅cm), 
hmdC 8.7 L/(mmol⋅cm), fdC 11.3 L/(mmol⋅cm), cadC 7.1 L/(mmol⋅cm). The 
1,2,3-triazole and abasic monomer are transparent at 260 nm. 
 
Click reaction on the solid support with azide linkers and deprotection 
After solid phase synthesis (0.2 μmol scale, approx. 50% yield for 13 mer, calculated 
as 0.1 μmol), the solid support was suspended in dimethyl sulfoxide (80 μL) and 
acetonitrile (25 μL). To the mixture, CuSO4 aq. (100 mM, 50 μL, 5.0 μmol, 50 eq.), 
sodium ascorbate aq. (500 mM, 20 μL, 10 μmol, 100 eq.), N,N-diisopropylethylamine 
solution in acetonitrile (200 mM, 75 μL, 15 μmol, 150 eq.), solution of 5 in dimethyl 
sulfoxide (100 mM, 50 μL, 5.0 μmol, 50 eq.) were added. The reaction was conducted 
at 25 °C for 24 h. Afterwards, the solid support was washed with dimethyl sulfoxide, 
dilute NaHCO3 aq., acetonitrile, ether and air-dried to a powder. The solid phase was 
then cleaved with conc. aqueous NH3 at 25 °C for 17 h, purified by HPLC and 
concentrated. The removal of the MMTr protection group on the hydroxylamine was 
carried out by dissolving the obtained oligonucleotide in acetic acid aq. (20%, 200 μL) 
at 25 °C for 30 min, precipitated by addition of sodium acetate solution (3 M, 60 μL) 




Schiff base formation between fdC-oligonucleotides and probe strands 
A mixture of fdC containing oligonucleotides (T1,2), or T/C/mC/hmC/caC/Abasic 
containing oligonucleotides (T3-8) in control experiments (15 μM, 20 μL, 0.3 nmol, 1 
eq.), probe strands (15 μM, 20 μL, 0.3 nmol, 1 eq.), NaCl aq. (1 M, 15 μL), NaOAc 
aq. (pH = 6.0, 100 mM, 15 μL) and ddH2O (80 μL) was prepared to make a final 
volume of 150 μL (oligonucleotide working concentration 2 μM). The mixture was 
heated to 85 °C for 5 min then slowly cooled down to 25 °C in 3 h. A first aliquot (15 
μL) was taken and quenched before 5.4 μL of 4-methoxyaniline solution (250 mM, 
ddH2O/DMSO, v/v 9/1, acidified to pH = 5.5 with acetate acid) was added to give a 
catalyst working concentration of 10 mM. The reaction was conducted at 25 °C, 500 
rpm for 24 h. Aliquots (15 μL) were taken at 1, 2, 4, 6, 8, 12, 24 h and quenched by 
addition of loading buffer. All the samples were heated at 85 °C for 3 min followed by 
PAGE assay as mentioned above.  
When using 1,4-benzenediamine as the catalyst, a 10 mM stock solution of 10 mM in 
0.5% acetic acid aq. was prepared. 
 
Melting point experiments 
Melting profiles were measured on a JASCO V-650 spectrometer using quartz glass 
cuvettes with 10 mm path length. The samples contained 100 mM NaCl, 10 mM 
NaOAc buffer pH 6.0 and 1 μM of each strand in a final volume of 200 μL. The 
measurement was repeated three times with independent sample. Before the 
measurement, the oligonucleotides were hybridized by slowly cooling down the 
samples from 85 °C to room temperature. The solutions were covered with silicon oil 
and tightly plugged. Absorbance was recorded in the forward and reverse direction at 
temperatures from 25 °C (or 15 °C) to 85 °C with a slope of 1 °C/min. TM values were 
calculated as the zero-crossing of 2nd derivate of the 339 nm background corrected 





Table S1. Synthesized oligonucleotides in this study. (Letters in bold and italic stand 
for 2’-O-propargyl nucleosides or epigenetic modifications.) 
 
Entry Description 5'-------------3' Calc. Exptl. 
T1 ODN-fC GTAATGfCGCTAGG 4040.9  4036.2  
T2 fC-shift GTAATfCCGCTAGG 4000.9  3999.6  
T3 fC-T GTAATGTGCTAGG 4027.7  4024.7  
T4 fC-C GTAATGCGCTAGG 4012.7  4008.6  
T5 fC-mC GTAATGmCGCTAGG 4026.7  4021.6  
T6 fC-hmC GTAATGhmCGCTAGG 4042.7  4039.6  
T7 fC-caC GTAATGcaCGCTAGG 4056.7  4054.9  
T8 fC-Abasic GTAATGAPGCTAGG 3919.6  3916.4  
P1 
Probe-1-alkyne CCUAGCGCATTAC 3932.7  3930.5  
Probe-1-MMTr CCUAGCGCATTAC 4335.2  4335.1  
Probe-1-ONH2 CCU*AGCGCATTAC 4084.8[a] 4084.2  
P2 
Probe-2-MMTr CCUATCGCATTAC 4310.2  4310.3  
Probe-2-ONH2 CCU*ATCGCATTAC 4059.8[a] 4064.3  







Figure S1. Typical HPLC trace of crude product a) P1-MMTr and b) P1-ONH2. 
Conditions: buffer A, 0.1 M TEAA; buffer B, 0.1 M TEAA in 80% acetonitrile, linear 
gradient from 0% to 60% B over 45 min. Retation time: (a) 34.4 min, (b) 18.5 min. 





5. Crosslinking studies with the synthesized strands 
 
 
Figure S2. Quantification of the DNA duplex formation during the reaction using the 
catalyst 4-methoxyaniline. Black line: duplex formation between T1 and P1, blue line: 
duplex formation between T2 and P1. Error bars represent the standard error of the 
mean calculated from three replicates. 
 
 
Figure S3. Model representation of a duplex showing the position of the 










No. 5'-------------3' Calc. Exptl. 
P1 CCU*AGCGCATTAC 4061.8  4060.5  
T1 GTAATGfCGCTAGG 4040.9  4038.4  
T1 GTAATGfCGCTAGG 4146.0[a] 4143.9  
T1:P1   8084.7  8081.9  
[a] conjugate with 4-methoxyaniline 
 
Figure S4. MALDI-TOF mass spectrum of the crosslinked duplex T1:P1 and single 
strands. a) Overall MALDI-TOF spectrum; b) peaks corresponding to single strands 
P1 and P1- 4-methoxyaniline conjugate; c) peaks corresponding to linked duplex 






Figure S5. Melting curves of duplex T1:P1 after reannealing or after 24 h incubation 
without catalyst compared with duplex T1 and its counter strand (positive control). 
Conditions: 1 μM oligonucleotides, 100 mM NaCl, 10 mM NaOAc buffer pH 6.0, the 








6. Experimental details of the genomic fdC profiling study 
 
Cell culture and genomic DNA isolation  
J1 wild type stem cells (strain 129/SvJae),[1] Dnmt TKO (J1, strain 129/SvJae),[2] 
Tdg+/- (E14, strain 129/Ola) and the Tdg-/- cell line (E14, strain 129/Ola),[3] were 
routinely maintained on gelatinized plates in DMEM (Sigma-Aldrich) supplemented 
with 10% FBS (PAN Biotech), 1x MEM-nonessential amino acids (NEAA), 0.2 mM 
L-alanyl-L-glutamine, 1x penicillin-streptomycin, 0.1 mM ß-mercaptoethanol (all 
from Sigma-Aldrich), 1000 U/ml mouse recombinant LIF (ORF Genetics), 1 μM PD 
0325901 and 3 μM CHIR 99021 (2i; both from Axon Medchem). In these conditions, 
global genomic mC levels are very low and its oxidized derivatives are even lower, as 
we described previously.[4] For the experiments, the cultures were passaged twice 
(over five days), in DMEM supplemented with FBS and LIF, but lacking 2i. With this 
strategy, primed mESC cultures were obtained and oxidized cytosine derivatives 
reached reproducibly higher and stable levels.[4] In case of the experiment using J1 
wild type and Dnmt TKO cells, the cultures were passaged every second day over a 
period of six days. 
Mouse embryonic stem cells were lysed directly in the plates with RLT-buffer 
(Qiagen). The lysates were homogenized with a TissueLyser MM400 (Retsch) for 
1 min at 30 Hz and centrifuged for 5 min at 21000 xg. Then genomic DNA was 
isolated using the Zymo Quick gDNA Midi Kit according to the manufacturer’s 
instruction. The concentration was measured using a Nanodrop ND-1000 (Peqlab). 
 
Probe crosslinking  
The gDNA solution obtained above (1.2 μg), the fdC probe (P) (1 μM, 2 μL), 
NaH2PO4-Na2HPO4 buffer (200 mM, pH = 6.0, 2 μL), NaCl aq. (1.5 M, 2μL), and 
ddH2O were mixed to a final volume of 18 μL. The mixture was heated to 95 °C for 3 
min, and then cooled down rapidly to 25 °C. 1,4-Benzenediamine aq. (10 mM, 2 μL) 
was added and the reaction vial shaken (300 rpm) for 6 h at 25 °C. First, the mixture 
was neutralized with Na2HPO4 aq. (200 mM, 40 μL), and then purification with NEB 
Monarch PCR DNA Cleanup Kit using the binding buffer (120 μL) and eluting with 
the elution buffer (Tris-EDTA) (30 μL). The eluted solution was quantified with the 
Nanodrop and 22-32 ng/μL was obtained. UV spectra confirmed the main peak 







The crosslinked gDNA solution (300 ng), reporter strand (R) (20 nM, 1 μL), 
Ampligase reaction buffer (10×, 2 μL), Ampligase from Epicenter (5 U/μL, 2 μL, 10 
U) and ddH2O were mixed to a final volume of 20 μL. The mixture was heated to 
95 °C for 3 min, and then to 94 °C for 1 min, 60 °C for 1 h and back to 94 °C for 10 
cycles. Then, the reaction mixture was diluted with Tris-HCl buffer (200 mM, pH = 
7.6, 50 μL) before purification with NEB Monarch PCR DNA Cleanup Kit using the 
binding buffer (140 μL) and eluting with the elution buffer (10 μL). The eluted 
solution was quantified with the Nanodrop, obtaining 20-32 ng/μL. UV spectra 
confirmed the main peak centered at 260 nm. 
 
Droplet digital PCR  
ddPCR experiments were performed on a Bio-Rad QX100 ddPCR System. For one 
reaction, gDNA (6 ng), four primers (18 μM each, 1 μL), two TaqMan probes (5 μM 
each, 1 μL), digital PCR Supermix for Probes (no dUTP, 2×, 10 μL), and ddH2O were 
mixed to a final volume of 20 μL with primer working concentration of 900 nM and 
TaqMan probe working concentration of 250 nM.  
PCR cycles were conducted on a Bio-Rad T100 Thermal cycler. PCR cycle: 95°C for 
10 min, 94°C for 30 sec and specific annealing temperature (64°C) for 1 min for 35 or 
40 cycles, then 98°C for 10 min and cooled down to 12°C. A temperature ramp of 
2°C/s was used. Droplet generation and counting were conducted according to the 
manufacturer’s instructions, i.e. reaction mixture prepared as above (20 μL) and 
ddPCR droplet generate oil (70 μL) were used per reaction. The accounted droplet 
number was retained in 10000-18000. FAM for detection amplicon was set to channel 
1; HEX for reference amplicon was set to channel 2.  
Each percentage value represents the averages and standard deviations from the mean 
of at least two technical replicates and two biological replicates. LC-MS 
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Figure S6. Sequence detail of the detection strategy: a) Illustration of the detection 
strategy with sequence details for locus 1, i.e. 30,020,539th position on chromosome 
16 (MM9); b) synthesized and purchased oligonucleotides for locus 1 and 2. Bold and 
red letters represent nucleoside modifications or functional group: p, phosphate group 
at 5’ terminus; F, FAM; H, HEX; Q, BHQ-1. MALDI-TOF: P2: calc.7951.5, found 









Figure S7. Global 5mC, 5hmC, fdC, and 5caC quantification using LC-MS: Tdg-/-, 
Tdg+/-, and Dnmt TKO mES cells and 0, 2, 4, 6 days during priming of wild-type mES 
cells.  *: <LOQ, below the limit of quantification.  
pro dN STABW% pro dN STABW% pro dN STABW% pro dN STABW%
Tdg-/- 1.0E-02 1.1 4.0E-04 1.1 1.8E-05 3.6 2.0E-06 7.3
Tdg+/- 1.1E-02 2.0 3.9E-04 11.3 3.7E-06 0.8 2.2E-07 22.3
Dnmt TKO 3.0E-06 28.0 3.8E-06 18.8 6.0E-07 6.8 * *
WT0 2.5E-03 1.7 1.5E-04 0.6 1.2E-06 1.9 * *
WT2 5.1E-03 1.6 2.6E-04 3.6 2.6E-06 3.3 2.2E-07 6.8
WT4 8.7E-03 2.4 4.2E-04 11.2 2.2E-06 0.8 * *





Figure S8. 2-D plot of droplet fluorescence for negative control of locus 1: a) P3, 





7. Quantification modeling 
 
The encapsulation maximum of one target amplicon in one droplet to generate a 
positive or negative signal is the ideal scenario for our situation. If a droplet contains 
more than one detection amplicon, for example, one contains one fdC and one 
cytosine, it will show a positive signal, and the negative cytosine signal vanishes.  
The probability for two or more detection amplicons to get into one droplet can be 
calculated according to the Poisson distribution, i.e. a discrete random variable X 
complies the Poisson distribution with parameter λ > 0, if, for k = 0, 1, 2, …, the 
probability mass function of X is given by: 
𝑓 (𝑘; λ) = Pr  (X = 𝑘) =  
λ𝑘𝑒−λ
𝑘!
       
where e is Euler's number and k! is the factorial of k.  
 




ng 1 2 3 4 5 
3 0.05  4.8% 0.1% 0.0% 0.0% 0.0% 
6 0.10  9.0% 0.5% 0.0% 0.0% 0.0% 
9 0.15  12.9% 1.0% 0.0% 0.0% 0.0% 
10 0.17  14.1% 1.2% 0.1% 0.0% 0.0% 
15 0.25  19.5% 2.4% 0.2% 0.0% 0.0% 
20 0.33  23.9% 4.0% 0.4% 0.0% 0.0% 
30 0.50  30.3% 7.6% 1.3% 0.2% 0.0% 
40 0.67  34.2% 11.4% 2.5% 0.4% 0.1% 
 
For example, the mass of a mouse genome is approximately 3.0 pg (3.0×10-12 g). If 30 
ng for a 20 μL reaction is used, 10,000 genomes will be distributed into 20,000 
droplets. So, λ equals to 10,000 / 20,000 = 0.50. Let X = 1, then f (1; 0.50) = 0.303; let 
X = 2, then f (2; 0.50) = 0.076. This means 30.3% of the droplets, instead 50% of the 
droplet, contain a single copy while 7.6% of the droplets contain two copies. 
Extensive distribution probabilities are listed in Table S2. If less than 9 ng is settled in 
a 20 μL reaction, the probability to have two copies inside one droplet will be lower 
than 1%. For the ease of calculation, 6 ng gDNA is used for each reaction of 20 μL, 





Figure S9. ddPCR output and modeling: a) 2-D plot of droplet fluorescence for 
illustration; b) clusters separation in four quadrants; c) algebraic simplification of 
counting numbers of the clusters. 
 
As shown in Figure S8, Ch1+Ch2+ (yellow) refers to droplets with both positive 
signals; Ch1+Ch2- (blue) refers to droplets with only detection (report strand) signal; 
Ch1-Ch2+ (green) refers to droplets with only reference (gDNA) signal; Ch1-Ch2- 
(black) refers to droplets without target locus and ligated product; AD refers to all the 
droplets accepted; resolution refers to the separation of the clusters. 
In principle, Ch1+Ch2+ shows the droplets that contain fdC sites in the target locus; 
Ch1+Ch2- indicates false-positive signals due to unspecific amplification and the 
dissociated ligated products; Ch1-Ch2+ shows the droplets containing only the target 
gDNA.  
 
Figure S10. Agarose gel showing gDNA degradation: Line 1, log 2 marker; line 2,3, 
gDNA (150 ng) after crosslinking; line 4,5, gDNA (150 ng) after ligation cycle, 95°C 






Without considering the dissociation of the ligated products, the unreacted probe 
which remained in the system will cause unspecific amplification, i.e. Ch1+Ch2- 
signals. Catalyst, acid buffer, and ligation cycles will cause gDNA degradation 
(Figure S9, giving more Ch1+Ch2- false-negative signals. However, Ch1+Ch2- and 
Ch1+Ch2- / Ch1-Ch2- resolution do not play a role in the mathematical modelling 
that we used. 
Assuming that all fdC at the target site is converted to the reporter strand via 
crosslinking and ligation, the yield is 100%. Assume that there are less than 150 
copies in 1 μL so that the Poisson distribution is exclusive in our model. 
Let a = Ch1+Ch2-, b = Ch1+Ch2+, c = Ch1-Ch2+, (Figure S8) A = Accepted droplet 
for the experiment entry, respectively, a’, b’, c’, and A’ for the control, i.e. TET 
knockout cell line. 
Let η = fdC content of the target site. 
Then,  
η =












𝑎′ refers to the degraded gDNA copy containing fdC at the target site 
that does not show in Ch2, (a −
A
𝐴′
𝑎′)/η refers to all the degraded gDNA copies. 








Herein, in this ideal model, without considering the dissociation of the ligated 
products, η is independent of a, a’, and c’, i.e. genome degradation and unspecific 
ligation do not affect fdC percentage. Ch1+Ch2- only be resulted from the 






is calculated to indicate relative abundance of fdC at the target site. 
 
In reality, neither the fdC probe covers all the target sites nor the reporter strand 
ligates to all the target-linked probe. Therefore, only relative quantification is possible 




8. Droplet digital PCR data 
 




Ch1 Ch2 1+2+ 1+2- 1-2+ 1-2- AD η Average
Tdg-/- 17.6 67.6 151 121 827 16399 17502 27.8%
Tdg-/- 17.6 63.7 101 93 590 12318 14896 28.1%
Tdg-/- 18.9 63.7 106 103 585 12308 13102 30.2%
Tdg-/- 28.8 103 181 149 1002 12743 14075 27.9%
Tdg+/- 11.6 74.0 54 56 676 11085 11878 15.1%
Tdg+/- 11.3 67.2 54 70 698 12722 13544 16.5%
Tdg+/- 10.7 69.6 52 83 806 13994 14935 15.7%
Tdg+/- 10.8 72.0 56 66 738 12490 13350 15.4%
Dnmt TKO 4.0 115.0 10 29 1049 10327 11415 3.7%
Dnmt TKO 3.1 61.1 11 17 625 11913 12566 4.4%
Dnmt TKO 4.1 58.0 14 30 620 12508 13174 6.9%
Dnmt TKO 2.8 60.6 8 21 600 11484 12119 4.8%




































Ch1 Ch2 1+2+ 1+2- 1-2+ 1-2- AD η Average
WT0 5.4 108 20 34 1017 10787 11858 5.21%
WT0 6.8 110 30 58 1336 13841 15265 6.44%
WT0 6.6 112 26 53 1255 12738 14072 6.17%
WT0 7.8 108 23 58 1241 13060 14382 6.41%
WT2 9.7 89.2 40 98 1193 15552 16883 11.19%
WT2 10.2 88.7 35 105 1249 15948 17337 10.90%
WT2 10.8 93.0 35 96 1168 14476 15771 10.89%
WT2 10.2 96.0 54 94 1279 15637 17064 11.10%
WT2 6.3 56.2 19 65 744 15582 16410 11.01%
WT2 6.0 57.3 27 54 759 15780 16620 10.31%
WT4 6.2 68.0 19 30 501 8702 9252 9.42%
WT4 5.4 68.4 26 46 811 13942 14821 8.60%
WT4 4.5 59.0 14 24 477 9449 9964 7.74%
WT4 5.8 64.5 23 43 688 12579 13333 9.28%
WT6 11.1 117 42 67 1081 10691 11881 9.71%
WT6 8.2 114 28 41 888 9000 9957 7.53%
WT6 9.8 120 32 41 820 7909 8802 8.57%





Well Ch1 Ch2 1+2+ 1+2- 1-2+ 1-2- AD η Average
H04 Tdg-/- 10.5 52 55 92 650 15671 16468 20.9%
E06 Tdg-/- 20.8 115 88 133 1084 11285 12590 18.9%
F06 Tdg-/- 22.5 114 98 173 1226 12805 14302 20.5%
G06 Tdg-/- 20.1 109 94 149 1178 12927 14348 19.1%
H06 Tdg-/- 21.8 116 90 159 1179 12141 13569 19.6%
B09 Tdg+/- 5.5 66 28 49 884 15696 16657 8.4%
A10 Tdg+/- 5.9 59 13 29 400 8002 8444 10.2%
E01 Tdg+/- 8.3 96 43 78 1299 15749 17169 9.0%
G01 Tdg+/- 8.1 93 39 73 1205 15070 16387 9.0%
19.8%
9.2%
